Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy E Lovett-Racke

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Journal of Neuroimmunology|August 22, 2016
Contribution of EAE to understanding and treating multiple sclerosisAmy E Lovett-Racke
Cellular Immunology|July 27, 2002
Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cellsAmy E Lovett-Racke, Michael K Racke
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2011
Glatiramer acetate treatment of multiple sclerosis: an immunological perspectiveMichael K Racke, Amy E Lovett-Racke
PPAR Research|January 15, 2011
Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARsYuhong Yang, Amy E Lovett-Racke, Michael K Racke
Trends in Immunology|June 1, 2005
PTX cruiser: driving autoimmunity via TLR4Michael K Racke, Wei Hu, Amy E Lovett-Racke
Biochimica Et Biophysica Acta|July 6, 2010
Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?Amy E Lovett-Racke, Yuhong Yang, Michael K Racke
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 2, 2014
Is T-bet a potential therapeutic target in multiple sclerosis?Michael K Racke, Yuhong Yang, Amy E Lovett-Racke
Neurology|December 30, 2009
The mechanism of action of glatiramer acetate treatment in multiple sclerosisMichael K Racke, Amy E Lovett-Racke, Nitin J Karandikar
Archives of Neurology|September 10, 2008
Monoclonal antibody therapies and neurologic disordersJohn C Novak, Amy E Lovett-Racke, Michael K Racke
European Journal of Immunology|January 20, 2017
TGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosisPriscilla W Lee, Mary E Severin, Amy E Lovett-Racke
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Journal of Neuroimmunology|August 22, 2016
Contribution of EAE to understanding and treating multiple sclerosisAmy E Lovett-Racke
Cellular Immunology|July 27, 2002
Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cellsAmy E Lovett-Racke, Michael K Racke
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2011
Glatiramer acetate treatment of multiple sclerosis: an immunological perspectiveMichael K Racke, Amy E Lovett-Racke
PPAR Research|January 15, 2011
Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARsYuhong Yang, Amy E Lovett-Racke, Michael K Racke
Trends in Immunology|June 1, 2005
PTX cruiser: driving autoimmunity via TLR4Michael K Racke, Wei Hu, Amy E Lovett-Racke
Biochimica Et Biophysica Acta|July 6, 2010
Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?Amy E Lovett-Racke, Yuhong Yang, Michael K Racke
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 2, 2014
Is T-bet a potential therapeutic target in multiple sclerosis?Michael K Racke, Yuhong Yang, Amy E Lovett-Racke
Neurology|December 30, 2009
The mechanism of action of glatiramer acetate treatment in multiple sclerosisMichael K Racke, Amy E Lovett-Racke, Nitin J Karandikar
Archives of Neurology|September 10, 2008
Monoclonal antibody therapies and neurologic disordersJohn C Novak, Amy E Lovett-Racke, Michael K Racke
European Journal of Immunology|January 20, 2017
TGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosisPriscilla W Lee, Mary E Severin, Amy E Lovett-Racke
Pageof 7